Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 7 Issue 2

Evaluation of the Relationship Between Serum Level of Vitamin D3 and Endothelial Function Tests in Patients with Migraine Headache

Mohammadreza Rezvani Valuklolaee1, Zahra Mirzaasgari2, Fatemeh Afrashteh1 *, Roya Ghafoury1 and Rayan Rajabi1

1School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2Assistant Professor of Neurology, Iran University of Medical Sciences, Tehran, Iran

*Corresponding Author: Fatemeh Afrashteh, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Received: December 16, 2022; Published: January 18, 2023


Introduction: Migraine is a severe headache type and has a negative effect on quality of life. Studies have confirmed the presence of vitamin D receptors in different regions of the human brain and the relation between vitamin D deficiency and neurologic disorders. Here we evaluated the association between migraine features and serum vitamin D levels.

Method: In this case analytical study, we included patients who were referred to the General Neurology Clinic from march 2020 to march 2021 with these criteria: Over 18 years of age, having a diagnosis of migraine with at least 3 attacks per month. Exclusion criteria included risk of vascular diseases including a history of heart attack or stroke, diabetes, hypertension, smoking, peripheral vascular disease, patients using statins, and patients who were in the acute migraine attack phase. Flow mediated dilation (FMD) of the brachial artery depending on the blood flow and carotid intima-media thickness (IMT) score were measured for the participants.

Results: The correlation coefficient between FMD and IMT values was r = -0.428 (p = 0.003). This association was not notable in migraine patients with aura (p = 0.065) but in the group of patients without aura, the results were significant (r = 0.379, p = 0.025). FMD and IMT were not associated with serum vitamin D level in all patients (p = 0.802 and p = 0.785 respectively).

Conclusion: We did not found a correlation between serum vitamin D level and FMD or IMT in migraine. FMD and IMT were correlated with each other only in patients without aura. Further studies are needed to investigate the role of vitamin D level in migraine features.

Keywords: Vitamin D; Migraine; Flow Mediated Dilation; Carotid Intima-Media Thickness


  1. “Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013”. Lancet (London, England)9995 (2015): 743-800.
  2. Vos T., et al. “Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. Lancet (London, England)9859 (2012): 2163-2196.
  3. Lipton RB., et al. “Migraine prevalence, disease burden, and the need for preventive therapy”. Neurology5 (2007): 343-349.
  4. Lateef TM., et al. “Physical comorbidity of migraine and other headaches in US adolescents”. The Journal of Pediatrics 2 (2012): 308-313.e1.
  5. Stewart WF., et al. “Lost productive time and cost due to common pain conditions in the US workforce”. Jama 18 (2003): 2443-2454.
  6. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia: An International Journal of Headache9 (2013): 629-808.
  7. Buse DC., et al. “Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers”. Journal of Neurology, Neurosurgery, and Psychiatry4 (2010): 428-432.
  8. Giffin NJ., et al. “Premonitory symptoms in migraine: an electronic diary study”. Neurology 6 (2003): 935-940.
  9. Lebedeva ER., et al. “The Yekaterinburg headache initiative: an interventional project, within the Global Campaign against Headache, to reduce the burden of headache in Russia”. The Journal of Headache and Pain 1 (2013): 101.
  10. Bigal ME., et al. “Migraine and cardiovascular disease: a population-based study”. Neurology 8 (2010): 628-635.
  11. Etminan M., et al. “Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies”. BMJ (Clinical research ed). 7482 (2005): 63.
  12. Schürks M., et al. “Migraine and cardiovascular disease: systematic review and meta-analysis”. BMJ (Clinical research ed) 339 (2009): b3914.
  13. Spector JT., et al. “Migraine headache and ischemic stroke risk: an updated meta-analysis”. The American Journal of Medicine 7 (2010): 612-624.
  14. Sacco S., et al. “Peripheral vascular dysfunction in migraine: a review”. The Journal of Headache and Pain1 (2013): 80.
  15. Tietjen GE. “Migraine as a systemic vasculopathy”. Cephalalgia: An International Journal of Headache9 (2009): 987-996.
  16. Rodríguez-Osorio X., et al. “Endothelial progenitor cells: a new key for endothelial dysfunction in migraine”. Neurology 5 (2012): 474-479.
  17. Artaza JN., et al. “Vitamin D and the cardiovascular system”. Clinical Journal of the American Society of Nephrology 9 (2009): 1515-1522.
  18. Autier P., et al. “Vitamin D status and ill health: a systematic review”. The lancet Diabetes and Endocrinology 2.1 (2014): 76-89.
  19. Parker GB., et al. “Vitamin D and depression”. Journal of Affective Disorders 208 (2017): 56-61.
  20. Atherton K., et al. “Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey”. Annals of the Rheumatic Diseases6 (2009): 817-822.
  21. Littlejohns TJ., et al. “Vitamin D and the risk of dementia and Alzheimer disease”. Neurology 10 (2014): 920-928.
  22. Eyles DW., et al. “Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease”. Frontiers in Neuroendocrinology 1 (2013): 47-64.
  23. Headache Classification Committee of the International Headache Society (IHS). “The International Classification of Headache Disorders, 3rd edition”. Cephalalgia: An International Journal of Headache1 (2018): 1-211.
  24. Gazerani P., et al. “A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D (3) supplementation in adult patients with migraine”. Current Medical Research and Opinion4 (2019): 715-723.
  25. Mottaghi T., et al. “The relationship between serum levels of vitamin D and migraine”. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences 18 (2013): S66-70.
  26. Zandifar A., et al. “Vitamin D status in migraine patients: a case-control study”. BioMed Research International 2014 (2014): 514782.
  27. Knutsen KV., et al. “Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway”. Scandinavian Journal of Primary Health Care3 (2010): 166-171.
  28. Straube S., et al. “Vitamin D and chronic pain”. PAIN®1-2 (2009): 10-13.
  29. Kjærgaard M., et al. “Association between headache and serum 25‐hydroxyvitamin D; the Tromsø study: Tromsø 6”. Headache: The Journal of Head and Face Pain10 (2012): 1499-1505.
  30. Loder E., et al. “The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines”. Headache6 (2012): 930-945.
  31. Lippi G., et al. “No evidence for an association of vitamin D deficiency and migraine: a systematic review of the literature”. BioMed Research International 2014 (2014).
  32. Wang Q., et al. “Ultrasonic assessment of carotid intima-media thickness in migraine: a meta-analysis”. The Journal of International Medical Research7 (2019): 2848-2855.
  33. Vernieri F., et al. “Patients with migraine with aura have increased flow mediated dilation”. BMC Neurology 1 (2010): 1-7.
  34. Larsen JS., et al. “Migraine and endothelial function: The HUNT3 Study”. Cephalalgia: An International Journal of Headache14 (2016): 1341-1349.
  35. González-Quintanilla V., et al. “Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator”. Cephalalgia: An International Journal of Headache6 (2016): 552-560.
  36. Yilmaz Avci A., et al. “Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study”. Neurological Sciences4 (2019): 703-711.


Citation: Fatemeh Afrashteh., et al. “Evaluation of the Relationship Between Serum Level of Vitamin D3 and Endothelial Function Tests in Patients with Migraine Headache”.Acta Scientific Medical Sciences 7.2 (2023): 92-98.


Copyright: © 2022 Fatemeh Afrashteh., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US